Product Wiki · Recalls · U.S. FDA — Device Enforcement

Lev5, REF CT1587B, 50 Susceptibility discs Levofloxacin 5 ug, IVD, CE 2797 — recall Z-1075-2025

U.S. FDA — Device Enforcement · United Kingdom · 2024-12-23 · Class II

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
U.S. FDA — Device Enforcement
Recall identifier
Z-1075-2025
Date of alert
2024-12-23
Country / jurisdiction
United Kingdom
Risk level
Class II
Risk type
recall
Brand
Oxoid Limited
Product category
device
Product type
Devices
Barcode (EAN/GTIN)
5032384079629
Reported risk: Mislabeling; Levofloxacin Antimicrobial susceptibility disc packaging may contain Norfloxacin Antimicrobial Susceptibility discs.
Primary source: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?start_search=1&

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.